期刊文献+

F5基因复合杂合变异导致遗传性凝血因子Ⅴ缺陷症的家系分析 被引量:1

The analysis of a pedigree with hereditary coagulation factor Ⅴ deficiency caused by compound heterozygous variation of F5 gene
原文传递
导出
摘要 目的对1个遗传性凝血因子Ⅴ(FⅤ)缺陷症家系进行基因变异分析,探讨其分子发病机制。方法先证者,女,32岁,自幼易鼻出血,通常自愈,2021年3月10日因摔伤致膝盖血肿到空军军医大学第一附属医院就诊。其家系成员均表示无出血等相关病史。采用凝固法检测凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)和凝血因子Ⅴ活性(FⅤ:C)。采用酶联免疫吸附试验(ELISA)检测FⅤ抗原(FⅤ:Ag)。采用Sanger测序法测定F5基因所有外显子及侧翼序列。采用ClustalX-2.1-win、PolyPhen-2及Swiss-PdbViewer软件分析错义变异位点的保守性、是否有害及其对蛋白质结构及功能的影响。采用MutationTaster及NetGene2软件分析剪切变异是否有害及其对剪切位点的影响。结果先证者PT和APTT延长为24.0 s和69.8 s,FⅤ:C和FⅤ:Ag分别降低为6%和9%;其F5基因存在复合杂合变异,分别为6号外显子c.911G>A杂合错义变异,导致p.Gly276Glu变异;15号内含子c.5208+1G>A杂合错义变异。先证者父亲和女儿携带p.Gly276Glu杂合变异;母亲和儿子携带c.5208+1G>A杂合变异。软件分析结果表明,p.Gly276Glu杂合变异的Gly276在同源物种间保守,该变异有害,会影响蛋白局部结构及功能;c.5208+1G>A杂合变异为有害变异,且变异导致剪切位点消失,从而影响蛋白功能。结论p.Gly276Glu和c.5208+1G>A复合杂合变异是与患者疾病相关的有害变异,可能是该家系遗传性FⅤ缺陷症的分子发病机制。 Objective To analyze the gene variation of a genetic coagulation factorⅤ(FⅤ)deficiency pedigree and explore the molecular pathogenesis.Methods The proband was a 32 years old female.The patient was prone to nose bleeding since childhood which was usually self-healed.On March 10,2021,the proband went to the First Affiliated Hospital of Air Force Medical University for treatment of knee hematoma caused by a fall.None of the family members reported any history of bleeding.The prothrombin time(PT),activated partial thromboplastin time(APTT)and FⅤactivity(FⅤ:C)were detected by clotting method and the FⅤantigen(FⅤ:Ag)was tested with enzyme-linked immunosorbent assay(ELISA).All exons and flanks of F5 gene were determined by Sanger sequencing.Clustalx-2.1-win,PolyPhen-2 and Swiss-PDBViewer software were used to analyze the conservatism of missense variation sites,whether the variations were harmful and their influences on protein structure and function.MutationTaster and NetGene2 software were used to analyze whether the splice site variation was harmful and its effect on the splice site.Results The PT and APTT of the proband prolonged to 24.0 s and 69.8 s,respectively.The FⅤ:C and FⅤ:Ag decreased to 6%and 9%,respectively.There were compound heterozygous variations in F5 gene,which included c.911G>A heterozygous missense variation in exon 6 leading to p.Gly276Glu variation and c.5208+1G>A heterozygous missense variation in intron 15.The father and daughter had the p.Gly276Glu heterozygous variation.Her mother and son had the c.5208+1G>A heterozygous variation.Software analysis results of p.Gly276Glu heterozygous variation showed that Gly276 was conserved among homologous species,the variation was harmful,and it could affect the local structure and function of the protein.The c.5208+1G>A heterozygous variation was deleterious and resulted in the disappearance of the splice site,thereby affecting the protein function.Conclusion The p.Gly276Glu and c.5208+1G>A compound heterozygous variants are deleterious variants associated with the patient′s disease and may be the molecular pathogenesis of inherited FⅤdeficiency in this family.
作者 程晓丽 杨婷 杨柳 辛毅娟 何睦 朱琳 刘家云 Cheng Xiaoli;Yang Ting;Yang Liu;Xin Yijuan;He Mu;Zhu Lin;Liu Jiayun(Department of Clinical Laboratory,the First Affiliated Hospital of Air Force Medical University,Xi′an 710032,China;Department of Clinical Laboratory,the Quzhou Affiliated Hospital(Quzhou People′s Hospital)of Wenzhou Medical University,Quzhou 324000,China)
出处 《中华医学杂志》 CAS CSCD 北大核心 2023年第17期1323-1327,共5页 National Medical Journal of China
关键词 凝血因子Ⅴ 错义变异 剪切位点变异 遗传性凝血因子Ⅴ缺陷症 Coagulation factorⅤ Missense variation Splice site variation Inherited coagulation factorⅤdeficiency
  • 相关文献

参考文献7

二级参考文献48

  • 1郑卫东,刘艳辉,刘辉芳,陈志红,王嬿.一个遗传性凝血因子Ⅴ缺乏症家系中凝血因子Ⅴ基因两种新突变的鉴定[J].中华医学遗传学杂志,2006,23(5):515-518. 被引量:4
  • 2Van Wijk R, Nieuwenhuis K, Vanden M, et al. Five novel mutations in the gene for human blood coagulation factor V associated with type I factor V deficiency. Blood, 2001, 98:358-367.
  • 3Chen TY, Lin TM, Chen HY,et al. Gly392Cys missense mutation in the A2 domain of factor V causing severe factor V deficiency:molecular characterization by expression of the recombinant protein. Thromb Haemost, 2005,93(3):614-615.
  • 4Seanavini D, Girelli D, Lunghi B,et al. Modulation of factor V levels in plasma by polymorphisms in the C2 domain. Arterioscler Thromb Vase Biol, 2004,24(1):200-206.
  • 5Soria JM, Blangero J, Souto JC, et al. Identification of a large deletion and three novel mutations in exon 13 of the factor V gene in a Spanish family with normal factor V coagulant and anticoagulant properties. Hum Genet, 2002,111:59-65.
  • 6Montefusco MC, Duga S, Asselta R, et al. A novel two base pair deletion in the factor V gene associated with severe factor V deficiency. Br J Haematol,2000,111:1240-1246.
  • 7Schrijver I, Hong DW, Mandle L, et al, High frequency of premature termination mutations in the factor V gene: three factor V deficiency case reports and a mutation review. Thromb Haemost,2005,g3(3) :610-611.
  • 8Schrijver I, Koerper MA, Jones CD, et al, Homozygous factor V splice site mutation associated with severe factor V deficiency.Blood, 2002,99 : 3063-3065.
  • 9Asselta R, Montefusco MC, Duga S , et al. Severe factor V deficiency: exon skipping in the factor V gene causing a partial deletion of the C1 domain. J Thromb Haemost, 2003,1:1237-1244.
  • 10Asselta R, Tenchini ML, Holme R, et al. The discovery of Mary's mutation. J Thromb Haemost,2003,1 : 397-398.

共引文献22

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部